---
title: "12 Health Care Stocks Moving In Wednesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295664907.md"
description: "In Wednesday's pre-market session, several healthcare stocks showed significant movement. Gainers included Bone Biologics (+17.7%), Definium Therapeutics (+17.69%), and Dermata Therapeutics (+17.59%). Conversely, major losers featured Silexion Therapeutics (-58.0%), Edap TMS (-20.97%), and SILO Pharma (-19.67%). These shifts occurred alongside various Q2 earnings releases."
datetime: "2026-08-12T12:06:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295664907.md)
  - [en](https://longbridge.com/en/news/295664907.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295664907.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

### Gainers

-   **Bone Biologics** (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6 million.
-   **Definium Therapeutics** (NASDAQ:DFTX) stock increased by 17.69% to $48.15. The market value of their outstanding shares is at $5.4 billion. The company's, Q2 earnings came out 4 days ago.
-   **Dermata Therapeutics** (NASDAQ:DRMA) stock increased by 17.59% to $1.27. The company's market cap stands at $4.3 million. As per the press release, Q2 earnings came out yesterday.
-   **Apyx Medical** (NASDAQ:APYX) shares moved upwards by 14.27% to $3.45. The company's market cap stands at $127.2 million. As per the press release, Q2 earnings came out 4 days ago.
-   **TransCode Therapeutics** (NASDAQ:RNAZ) shares moved upwards by 13.7% to $3.9. The market value of their outstanding shares is at $3.6 million.
-   **Innate Pharma** (NASDAQ:IPHA) shares rose 12.55% to $2.42. The market value of their outstanding shares is at $201.7 million.

### Losers

-   **Silexion Therapeutics** (NASDAQ:SLXN) stock decreased by 58.0% to $0.43 during Wednesday's pre-market session. The company's market cap stands at $1.1 million.
-   **Edap TMS** (NASDAQ:FOCL) shares declined by 20.97% to $4.75. The market value of their outstanding shares is at $225.2 million.
-   **SILO Pharma** (NASDAQ:SILO) stock fell 19.67% to $2.86. The market value of their outstanding shares is at $4.0 million.
-   **Concord Medical Services** (NYSE:CCM) stock decreased by 15.06% to $4.4. The market value of their outstanding shares is at $22.4 million.
-   **Cryo-Cell International** (AMEX:CCEL) shares declined by 14.53% to $3.0. The company's market cap stands at $28.2 million.
-   **Milestone Pharmaceuticals** (NASDAQ:MIST) shares declined by 11.82% to $1.12. The company's market cap stands at $158.1 million. The company's, Q2 earnings came out today. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [SILO.US](https://longbridge.com/en/quote/SILO.US.md)
- [SLXN.US](https://longbridge.com/en/quote/SLXN.US.md)
- [DRMA.US](https://longbridge.com/en/quote/DRMA.US.md)
- [DFTX.US](https://longbridge.com/en/quote/DFTX.US.md)
- [FOCL.US](https://longbridge.com/en/quote/FOCL.US.md)
- [DRMAW.US](https://longbridge.com/en/quote/DRMAW.US.md)
- [BBLG.US](https://longbridge.com/en/quote/BBLG.US.md)
- [APYX.US](https://longbridge.com/en/quote/APYX.US.md)
- [RNAZ.US](https://longbridge.com/en/quote/RNAZ.US.md)
- [IPHA.US](https://longbridge.com/en/quote/IPHA.US.md)
- [CCM.US](https://longbridge.com/en/quote/CCM.US.md)
- [CCEL.US](https://longbridge.com/en/quote/CCEL.US.md)
- [MIST.US](https://longbridge.com/en/quote/MIST.US.md)
- [BBLGW.US](https://longbridge.com/en/quote/BBLGW.US.md)
- [SLXNW.US](https://longbridge.com/en/quote/SLXNW.US.md)

## Related News & Research

- [Bone Biologics to participate in H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297914439.md)
- [Silexion Therapeutics publishes corporate deck spotlighting SIL204 siRNA program targeting KRAS-driven cancers](https://longbridge.com/en/news/295325850.md)
- [Definium Therapeutics (DFTX) Receives a Buy from Wells Fargo](https://longbridge.com/en/news/295787298.md)
- [What Do Definium Therapeutics (DFTX) Phase 3 GAD Results Mean For DT120?](https://longbridge.com/en/news/295821556.md)
- [Jim Cramer: This Health Care Stock Is Pure Spec, The Only Neocloud I Like Is...](https://longbridge.com/en/news/298031881.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**